Inspection of Sputnik V production sites completed

The European Medicines Agency announced the completion of an inspection of the sites where the Russian vaccine is produced. According to Marco Cavalieri, head of the agency’s Vaccination Department, specialists are currently awaiting the rest of the information on Sputnik V.

He found it difficult to name a timeframe for reviewing the vaccine’s dossier for admission to the EU, but pointed out that the agency will base its decision on the risk-benefit ratio.

The start of the vaccine review process was announced in early March.